| Year | Firm | Client | Income | Doc |
|---|---|---|---|---|
| 2026 1st Quarter - Report |
ARNOLD & PORTER KAYE SCHOLER LLP | SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | $60,000 | |
| 2026 1st Quarter - Report |
ARNOLD & PORTER KAYE SCHOLER LLP | EXELIXIS, INC. | $60,000 | |
| 2026 1st Quarter - Report |
ARNOLD & PORTER KAYE SCHOLER LLP | URAC, INC. | $70,000 | |
| 2026 1st Quarter - Report |
ARNOLD & PORTER KAYE SCHOLER LLP | SUMITOMO PHARMA AMERICA, INC. | $40,000 | |
| 2026 1st Quarter - Report |
ARNOLD & PORTER KAYE SCHOLER LLP | RECORDATI RARE DISEASES INC. | $60,000 | |
| 2026 Registration |
ARNOLD & PORTER KAYE SCHOLER LLP | SUMITOMO PHARMA AMERICA, INC. | — | |
| 2025 4th Quarter - Report |
ARNOLD & PORTER KAYE SCHOLER LLP | EXELIXIS, INC. | $60,000 | |
| 2025 4th Quarter - Report |
ARNOLD & PORTER KAYE SCHOLER LLP | SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | $60,000 | |
| 2025 4th Quarter - Report |
ARNOLD & PORTER KAYE SCHOLER LLP | URAC, INC. | $70,000 | |
| 2025 4th Quarter - Report |
ARNOLD & PORTER KAYE SCHOLER LLP | RECORDATI RARE DISEASES INC. | $60,000 |